A detailed history of Glenview Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Glenview Trust CO holds 190,047 shares of LLY stock, worth $151 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares
190,047
Previous 193,106 1.58%
Holding current value
$151 Million
Previous $175 Million 3.7%
% of portfolio
3.28%
Previous 3.61%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $2.36 Million - $2.94 Million
-3,059 Reduced 1.58%
190,047 $168 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $3.24 Million - $4.07 Million
-4,473 Reduced 2.26%
193,106 $175 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $651,420 - $871,508
1,100 Added 0.56%
197,579 $154 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $549,348 - $647,609
-1,046 Reduced 0.53%
196,479 $115 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $5.95 Million - $8.2 Million
-13,679 Reduced 6.48%
197,525 $106 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $7.65 Million - $10.2 Million
-21,819 Reduced 9.36%
211,204 $99.1 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $29.5 Million - $34.6 Million
94,826 Added 68.62%
233,023 $80 Million
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $759,179 - $884,595
-2,361 Reduced 1.68%
138,197 $50.6 Million
Q3 2022

Nov 04, 2022

SELL
$296.48 - $337.87 $647,215 - $737,570
-2,183 Reduced 1.53%
140,558 $45.5 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $2.33 Million - $2.73 Million
-8,348 Reduced 5.53%
142,741 $46.3 Million
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $1.01 Million - $1.26 Million
4,314 Added 2.94%
151,089 $43.3 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $813,057 - $1.01 Million
3,616 Added 2.53%
146,775 $40.5 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $688,732 - $847,582
3,108 Added 2.22%
143,159 $33.1 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $3.61 Million - $4.67 Million
19,991 Added 16.65%
140,051 $32.1 Million
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $7.83 Million - $10.1 Million
47,638 Added 65.78%
120,060 $22.4 Million
Q4 2020

Feb 02, 2021

SELL
$130.46 - $172.63 $48,531 - $64,218
-372 Reduced 0.51%
72,422 $12.2 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $239,508 - $277,034
-1,638 Reduced 2.2%
72,794 $10.8 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $424,948 - $511,420
-3,115 Reduced 4.02%
74,432 $12.2 Million
Q1 2020

Apr 28, 2020

BUY
$119.05 - $147.35 $8,571 - $10,609
72 Added 0.09%
77,547 $10.8 Million
Q4 2019

Feb 06, 2020

SELL
$106.92 - $132.43 $160,166 - $198,380
-1,498 Reduced 1.9%
77,475 $10.2 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $222,123 - $241,612
2,080 Added 2.71%
78,973 $8.83 Million
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $271,435 - $316,834
-2,450 Reduced 3.09%
76,893 $0
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $28,161 - $33,148
-253 Reduced 0.32%
79,343 $10.3 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $39,500 - $44,252
373 Added 0.47%
79,596 $9.21 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $9,873 - $12,340
-115 Reduced 0.14%
79,223 $8.5 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $135,275 - $155,254
-1,787 Reduced 2.2%
79,338 $6.77 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $79,404 - $93,732
-1,070 Reduced 1.3%
81,125 $0
Q4 2017

Feb 06, 2018

SELL
$81.94 - $87.89 $53,670 - $57,567
-655 Reduced 0.79%
82,195 $6.94 Million
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $6.39 Million - $7.09 Million
82,850
82,850 $7.09 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.